SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[EMPLOYMENT AGREEMENT Agreement Executive Company This EMPLOYMENT AGREEMENT (this “ WHEREAS, the Company desires to employ Executive as its Chief Financial Officer on the terms and conditions as set forth hereinafter, and Executive desires to be so employed; NOW, THEREFORE, IN CONSIDERATION of the foregoing facts, the mutual covenants and agreements contained herein and other good and valuable consideration, the] [SERVICES AGREEMENT 16 This SERVICES AGREEMENT (this “Agreement”), dated as of April RECITALS: B. The Parties have previously entered into an agreement setting forth the terms for the services of the Consultant as the Representative through March 31, 2010. C. At the request of the Company, the Consultant has continued to provide services to the Company as the Representative since] [SKYSTAR BIO-PHARMACEUTICAL COMPANY RESTRICTED STOCK AWARD AGREEMENT This Restricted Stock Award Agreement Agreement Company Grantee In consideration of the covenants herein set forth, the parties hereto agree as follows: Stock Award Information. 1. (a) Date of Award: April 16, 2010 (b) Grantee: R. Scott Cramer (c) Number of Shares: 10,000 (d) Original Value: $ (e) Amount Paid for Shares by] [SKYSTAR APPOINTS NEW CHIEF FINANCIAL OFFICER Michael H. Lan to Become Permanent CFO XI'AN, CHINA – April 19, 2010 - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Mr. Lan has advanced knowledge of U.S. GAAP and financial reporting requirements and has held internal financial control and audit positions with Silgan Containers Corporation and Gilead Sciences. Immediately prior to joining]
